Adaptam Therapeutics

About Adaptam Therapeutics

Adaptam Therapeutics is a biotech company based in San Sebastián, Spain, developing antibody‑based cancer immunotherapies that target the immunosuppressive myeloid tumor microenvironment. Their pipeline includes novel antibodies, antibody‑drug conjugates and bispecifics against glycan‑binding proteins and Siglecs on tumor‑associated macrophages, backed by public grants and venture capital.